Phase Ib Trial of HER2/Neu Peptide (E75) Vaccine in Node Negative Breast Cancer Patients.
Phase of Trial: Phase I/II
Latest Information Update: 14 Jul 2014
At a glance
- Drugs Nelipepimut-S (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Jun 2013 Status changed from active, no longer recruiting to completed, according to a Galena Biopharma media release.
- 05 Jun 2013 Results of this trial and SN 33 [Profile 700020465 ] presented at American Society of Clinical Oncologists (ASCO) 2013 Annual Meeting, according to a Galena Biopharma media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History